Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDialight Regulatory News (DIA)

Share Price Information for Dialight (DIA)

Share Price is delayed by 15 minutes
Get Live Data
381.00    8.00 (2.14%)
Bid:
379.00
Ask:
400.00
Spread: 21.00 (5.541%)
Market Cap: £152.30m
DIA Live PriceLast checked at - London Stock Exchange

Intraday Dialight Share Chart

Director/PDMR Shareholding

6 Mar 2017 13:45

RNS Number : 6403Y
Dialight PLC
06 March 2017
 

 

Dialight plc (the "Company")

 

Director/PDMR Shareholding

 

6 March 2017

 

 

 

The Company has been notified that on Friday, 3 March 2017, Fariyal Khanbabi, Executive Director and Group Finance Director of the Company, entered into the following transactions:

 

1. The exercise of a nil cost option over 10,445 ordinary shares of £0.0189 each in the Company ("Shares"), such option having been granted in March 2015 as a deferred share award under the Dialight plc Annual Performance Bonus Plan.

 

2. The sale of 4,962 Shares, acquired pursuant to the option exercise, at a price of £10.31 per share in order to satisfy the withholding tax payable in connection with the exercise and the commission arising on the sale.

 

Following this transaction, Fariyal Khanbabi now holds a total of 5,483 Shares, representing 0.017% of the total issued share capital of the Company.

 

This notification was received by the Company on 6 March 2017 and was made in accordance with the Market Abuse Regulation and Disclosure Transparency Rules.

 

 

For more information, contact:

 

Chris Fussell

General Counsel and Company Secretary

Tel: +44 (0) 203 058 3546

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUGUPCWUPMGWQ
Date   Source Headline
17th Apr 20237:00 amRNSDirector/PDMR Shareholding
14th Apr 20231:03 pmRNSDirector/PDMR Shareholding
12th Apr 202312:30 pmRNSNotice of AGM
6th Apr 20232:35 pmRNSTotal Voting Rights
6th Apr 20232:20 pmRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSDirectorate Change
3rd Apr 20231:03 pmRNSBlock listing Interim Review
3rd Apr 20237:00 amRNSAnnual Financial Report
30th Mar 20237:00 amRNSDirectorate Change
27th Mar 20237:00 amRNSFinal Results
20th Mar 20237:00 amRNSDirectorate Change
15th Mar 20235:14 pmRNSDirector Declaration
15th Mar 20237:00 amRNSSanmina Litigation
13th Jan 20237:00 amRNSDirectorate Change
13th Jan 20237:00 amRNSTrading Statement
5th Jan 20234:40 pmRNSSecond Price Monitoring Extn
5th Jan 20234:35 pmRNSPrice Monitoring Extension
14th Dec 202212:49 pmRNSDirectorate Change
1st Dec 20224:41 pmRNSSecond Price Monitoring Extn
1st Dec 20224:36 pmRNSPrice Monitoring Extension
23rd Nov 20227:00 amRNSTrading Statement
26th Oct 20227:00 amRNSDirectorate Change
11th Oct 20222:26 pmRNSHolding(s) in Company
3rd Oct 20225:50 pmRNSBlock listing Interim Review
1st Aug 20227:00 amRNSHalf-year Report
5th Jul 20221:46 pmRNSHolding(s) in Company
15th Jun 20227:00 amRNSAppointment of Corporate Broker
6th Jun 20227:00 amRNSDirector/PDMR Shareholding
24th May 20224:40 pmRNSSecond Price Monitoring Extn
24th May 20224:36 pmRNSPrice Monitoring Extension
23rd May 20224:41 pmRNSSecond Price Monitoring Extn
23rd May 20224:35 pmRNSPrice Monitoring Extension
19th May 202212:51 pmRNSResult of AGM
19th May 20227:00 amRNSTrading Statement
16th May 20224:23 pmRNSHolding(s) in Company
11th May 202211:07 amRNSHolding(s) in Company
5th May 20227:25 amRNSSmaller related party transaction & voting rights
4th May 20223:58 pmRNSHolding(s) in Company
3rd May 20223:11 pmRNSTotal Voting Rights
25th Apr 20224:34 pmRNSAdditional Listing
22nd Apr 20224:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20224:36 pmRNSPrice Monitoring Extension
14th Apr 20221:55 pmRNSNotice of AGM
14th Apr 202210:44 amRNSDirector/PDMR Shareholding
13th Apr 20224:40 pmRNSSecond Price Monitoring Extn
13th Apr 20224:35 pmRNSPrice Monitoring Extension
12th Apr 20225:27 pmRNSDirector/PDMR Shareholding
6th Apr 20229:58 amRNSDirector/PDMR Shareholding
6th Apr 20229:53 amRNSDirector/PDMR Shareholding
5th Apr 20223:07 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.